CHIA-CHI LINJANN-YUAN WANGYEONG-SHIAU PU2020-08-132020-08-1320130732-183Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84883892847&doi=10.1200%2fJCO.2013.49.6679&partnerID=40&md5=2d0a7540ba2f54367ea73b3110ac63d0https://scholars.lib.ntu.edu.tw/handle/123456789/512471[SDGs]SDG3bevacizumab; interleukin 10; temsirolimus; antineoplastic agent; comorbidity; disease predisposition; hematologic malignancy; human; kidney carcinoma; letter; lung lesion; Mycobacterium; patient monitoring; priority journal; protein blood level; tuberculosis; kidney carcinoma; kidney tumor; male; microbiology; note; tuberculosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Tuberculosisletter10.1200/JCO.2013.49.6679239914312-s2.0-84883892847